Showing results (21-30 of 76) with videos related to
Sort By:
Pageof 8
American Journal of Blood Research|February 1, 2022
Imatinib-induced retroperitoneal fibrosis in a child with chronic myeloid leukemia: a case reportSwaminathan Keerthivasagam, Nirmalya Roy Moulik, Ankita Pandey, et al.Indian Journal of Pediatrics|June 28, 2023
Treatment of Pediatric Acute Promyelocytic Leukemia with Retinoic Acid and Arsenic Trioxide along with ChemotherapyShyam Srinivasan, Chetan Dhamne, Nirmalya Roy Moulik, et al.Pediatric Blood & Cancer|November 15, 2019
Clinical profile and outcome of classical Hodgkin lymphoma treated with a risk-adapted approach in a tertiary cancer center in IndiaBadira Cheriyalinkal Parambil, Gaurav Narula, Maya Prasad, et al.Ecancermedicalscience|July 12, 2026
Nutritional status at diagnosis and follow-up and its impact on short-term clinical outcome in children with cancer: a real-world report from IndiaRajul M Gala, Maya Prasad, Shyam Srinivasan, et al.Leukemia & Lymphoma|July 31, 2020
Assessment of tumor Epstein-Barr Virus status and its impact on outcomes in intermediate and high-risk childhood classic Hodgkin Lymphoma treated at a tertiary cancer center in IndiaBadira Cheriyalinkal Parambil, Gaurav Narula, Chetan Dhamne, et al.Journal of Pediatric Hematology/Oncology|December 10, 2019
A Retrospective Analysis of Invasive Fungal Diseases (IFD) of the Central Nervous System in Children With Lymphoid MalignanciesSubramaniam Ramanathan, Shruti Kate, Seema Kembhavi, et al.Indian Journal of Pediatrics|August 11, 2021
COVID-19 in Children with Cancer and Continuation of Cancer-Directed Therapy During the InfectionBadira Cheriyalinkal Parambil, Nirmalya Roy Moulik, Chetan Dhamne, et al.Leukemia & Lymphoma|November 28, 2019
Favorable outcomes and reduced toxicity with a novel vinblastine-based non-high dose methotrexate (HDMTX) regimen (modified MCP-842) in pediatric anaplastic large cell lymphoma (ALCL): experience from IndiaKalasekhar Vijayasekharan, Maya Prasad, Nirmalya D Pradhan, et al.Cancer Chemotherapy and Pharmacology|October 17, 2022
A prospective, open-label, randomised, parallel design study of 4 generic formulations of intramuscular L-asparaginase in childhood precursor B-cell acute lymphoblastic leukaemia (ALL)Suja Johnson, Chetan Dhamne, Hari Sankaran, et al.Implementation Science Communications|June 11, 2022
Evaluating blinatumomab implementation in low- and middle-income countries: a study protocolCaitlyn Duffy, Victor Santana, Hiroto Inaba, et al.Pageof 8